Scopus Biopharma Inc (SCPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,975 | 7,943 | 3,632 | 6,261 | 8,256 |
| TOTAL | $4,604 | $8,185 | $4,029 | $6,805 | $8,625 |
| Non-Current Assets | |||||
| PPE Net | 3 | 3 | 3 | 4 | 2 |
| TOTAL | $3 | $3 | $3 | $4 | $2 |
| Total Assets | $4,608 | $8,188 | $4,032 | $6,808 | $8,627 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,138 | 4,170 | 2,237 | 2,574 | 1,936 |
| Other current liabilities | N/A | N/A | N/A | 3,415 | N/A |
| TOTAL | $5,138 | $4,170 | $2,237 | $8,792 | $4,479 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $5,138 | $4,170 | $2,237 | $8,792 | $4,479 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 21,094 | 21,094 | 18,094 | 18,094 | 15,728 |
| Common Shares | 21 | 21 | 18 | 18 | 16 |
| Retained earnings | -46,116 | -41,455 | -34,936 | -33,536 | -17,907 |
| Other shareholders' equity | -69 | -87 | -1,566 | -1,560 | -1,548 |
| TOTAL | $-530 | $4,017 | $1,794 | $-1,984 | $4,148 |
| Total Liabilities And Equity | $4,608 | $8,188 | $4,032 | $6,808 | $8,627 |